TherapeuticsMD Inc
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors an… Read more
TherapeuticsMD Inc (TXMD) - Total Liabilities
Latest total liabilities as of September 2025: $11.23 Million USD
Based on the latest financial reports, TherapeuticsMD Inc (TXMD) has total liabilities worth $11.23 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
TherapeuticsMD Inc - Total Liabilities Trend (1994–2024)
This chart illustrates how TherapeuticsMD Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
TherapeuticsMD Inc Competitors by Total Liabilities
The table below lists competitors of TherapeuticsMD Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sanko Pazarlama Ithalat Ihracat AS
IS:SANKO
|
Turkey | TL1.63 Billion |
|
Alony Hetz Properties and Investments Ltd
TA:ALHE
|
Israel | ILA34.61 Billion |
|
Three A Resources Bhd
KLSE:0012
|
Malaysia | RM48.38 Million |
|
University Bancorp Inc
OTCQB:UNIB
|
USA | $219.58 Million |
|
National Plastic Co Ltd Preferred
KO:004255
|
Korea | ₩168.34 Billion |
|
Munjal Auto Industries Limited
NSE:MUNJALAU
|
India | ₹8.52 Billion |
|
United Recommend International Co Ltd
TWO:5321
|
Taiwan | NT$4.14 Billion |
|
Lycos Energy Inc.
F:G4P0
|
Germany | €39.98 Million |
Liability Composition Analysis (1994–2024)
This chart breaks down TherapeuticsMD Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.46 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.41 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.29 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how TherapeuticsMD Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for TherapeuticsMD Inc (1994–2024)
The table below shows the annual total liabilities of TherapeuticsMD Inc from 1994 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $11.45 Million | -18.33% |
| 2023-12-31 | $14.02 Million | -74.65% |
| 2022-12-31 | $55.31 Million | -78.98% |
| 2021-12-31 | $263.09 Million | -13.91% |
| 2020-12-31 | $305.61 Million | +19.01% |
| 2019-12-31 | $256.78 Million | +124.34% |
| 2018-12-31 | $114.46 Million | +759.23% |
| 2017-12-31 | $13.32 Million | -11.09% |
| 2016-12-31 | $14.98 Million | +40.47% |
| 2015-12-31 | $10.67 Million | -0.23% |
| 2014-12-31 | $10.69 Million | +46.08% |
| 2013-12-31 | $7.32 Million | +0.92% |
| 2012-12-31 | $7.25 Million | +130.16% |
| 2011-12-31 | $3.15 Million | +129.14% |
| 2010-12-31 | $1.37 Million | +18.45% |
| 2009-12-31 | $1.16 Million | +3149.59% |
| 2008-12-31 | $35.72K | -54.10% |
| 2007-12-31 | $77.83K | -56.72% |
| 2006-12-31 | $179.83K | -63.54% |
| 2005-12-31 | $493.18K | +1228.79% |
| 2004-12-31 | $37.12K | +15.59% |
| 2003-12-31 | $32.11K | +91.08% |
| 2002-12-31 | $16.80K | -27.06% |
| 2001-12-31 | $23.04K | +42.16% |
| 2000-12-31 | $16.21K | -9.00% |
| 1999-12-31 | $17.81K | -64.89% |
| 1998-12-31 | $50.72K | +626.39% |
| 1997-12-31 | $6.98K | +44.76% |
| 1996-12-31 | $4.82K | -92.52% |
| 1995-12-31 | $64.49K | +462.21% |
| 1994-12-31 | $11.47K | -- |